8 days ago
J.J. McCarthy has given New York Giants head coach John Harbaugh plenty to consider after an encouraging display off the bench in their 34-27 defeat to the New Orleans Saints.
The quarterback replaced Jameis Winston in the second half and helped the Giants fight back from a 24-point deficit. Although New York fell short, McCarthy's performance could put him in contention to start their next game.
The former first-round pick completed 11 of his 21 pass attempts for 243 yards, one touchdown and one interception, offering a bright spot in a difficult afternoon for the Giants.
McCarthy also made sure to acknowledge the support he received from New York's fanbase, despite the disappointing result.
Speaking to reporters after the game, the quarterback said: "I'm just extremely honored to be a part of the New York Football Giants, because this fanbase is unbelievable.
#Giants #fanbase #john #harbaugh
The quarterback replaced Jameis Winston in the second half and helped the Giants fight back from a 24-point deficit. Although New York fell short, McCarthy's performance could put him in contention to start their next game.
The former first-round pick completed 11 of his 21 pass attempts for 243 yards, one touchdown and one interception, offering a bright spot in a difficult afternoon for the Giants.
McCarthy also made sure to acknowledge the support he received from New York's fanbase, despite the disappointing result.
Speaking to reporters after the game, the quarterback said: "I'm just extremely honored to be a part of the New York Football Giants, because this fanbase is unbelievable.
#Giants #fanbase #john #harbaugh
8 days ago
Real Madrid secured an important 4-1 victory over Sevilla at the Santiago Bernabeu in an encouraging performance from Jose Mourinho's side.
After the match, Eder Militao shared an emotional message with Real Madrid supporters following his long-awaited return to action.
The Brazilian came on as a second-half substitute and described the reception he received from the home crowd as unforgettable.
He took to Instagram following the victory, expressing his gratitude to the fans, his family and his team-mates after a lengthy spell on the sidelines.
Militao's appearance against Sevilla marked a significant milestone in his recovery, following 181 days away from competitive action.
#following #victory #jose
After the match, Eder Militao shared an emotional message with Real Madrid supporters following his long-awaited return to action.
The Brazilian came on as a second-half substitute and described the reception he received from the home crowd as unforgettable.
He took to Instagram following the victory, expressing his gratitude to the fans, his family and his team-mates after a lengthy spell on the sidelines.
Militao's appearance against Sevilla marked a significant milestone in his recovery, following 181 days away from competitive action.
#following #victory #jose
20 days ago
Jamie Lee Curtis came from Hollywood royalty: parents Janet Leigh and Tony Curtis
Janet and Tony welcomed daughters Jamie Lee and Kelly Lee before divorcing in 1962
The Oscar-winning actress has previously credited both of her parents for encouraging her to pursue a career in acting
Jamie Lee Curtis inherited the acting gene from her parents, Janet Leigh and Tony Curtis.
The Halloween actress was born in November 1958 — seven years after Janet and Tony married in 1951. Jamie Lee was raised alongside her older sister, the late Kelly Lee Curtis, in Los Angeles. After Janet and Tony divorced in 1962, Janet took primary care of the girls, which resulted in a deep bond between the mother and her daughters.
#curtis #daughters
Janet and Tony welcomed daughters Jamie Lee and Kelly Lee before divorcing in 1962
The Oscar-winning actress has previously credited both of her parents for encouraging her to pursue a career in acting
Jamie Lee Curtis inherited the acting gene from her parents, Janet Leigh and Tony Curtis.
The Halloween actress was born in November 1958 — seven years after Janet and Tony married in 1951. Jamie Lee was raised alongside her older sister, the late Kelly Lee Curtis, in Los Angeles. After Janet and Tony divorced in 1962, Janet took primary care of the girls, which resulted in a deep bond between the mother and her daughters.
#curtis #daughters
22 days ago
Meghan Markle is reportedly planning to do another round of an explosive tell-all interview with the support of her husband, Prince Harry. For those unversed, Harry and Markle stepped down as working royals and relocated to the U.S. in 2020. The couple participated in various interviews, sharing their honest, critical thoughts on the royal family, including the Oprah Winfrey show and their self-titled documentary. This move comes after the massive uproar reportedly caused by Princess Diana's brother's memoir.
Sources close to Closer revealed that Meghan Markle wants to give a big interview, mirroring Princess Diana's 1995 Panorama interview. According to sources, the Suits star is aware that it might cause a backlash, as her Oprah interview did a couple of years ago. However, she is keen on setting the record straight, in her own words.
The source said, "Now, she thinks it's time for her to speak out again. She wants a Diana moment – in the same way that she shocked everyone with her Panorama interview." The insider explained that the Sussexes' PR team is worried that it may generate major controversy. However, Prince Harry is on board with this, as he remembers how the royal family seemingly mistreated his wife. He does not want the same for Markle and is encouraging her to speak her truth.
"He doesn't want her to feel silenced – he wants her to speak out," the source added. If Markle does go ahead with the tell-all interview, it would be another blow to the royal family's reputation after Charles Spencer's book.
For those unversed, Spencer has levied some controversial allegations against the royal family, particularly her former brother-in-law, King Charles. The Daily Mail published an excerpt detailing an explosive phone call between the king and Spencer.
#markle
Sources close to Closer revealed that Meghan Markle wants to give a big interview, mirroring Princess Diana's 1995 Panorama interview. According to sources, the Suits star is aware that it might cause a backlash, as her Oprah interview did a couple of years ago. However, she is keen on setting the record straight, in her own words.
The source said, "Now, she thinks it's time for her to speak out again. She wants a Diana moment – in the same way that she shocked everyone with her Panorama interview." The insider explained that the Sussexes' PR team is worried that it may generate major controversy. However, Prince Harry is on board with this, as he remembers how the royal family seemingly mistreated his wife. He does not want the same for Markle and is encouraging her to speak her truth.
"He doesn't want her to feel silenced – he wants her to speak out," the source added. If Markle does go ahead with the tell-all interview, it would be another blow to the royal family's reputation after Charles Spencer's book.
For those unversed, Spencer has levied some controversial allegations against the royal family, particularly her former brother-in-law, King Charles. The Daily Mail published an excerpt detailing an explosive phone call between the king and Spencer.
#markle
22 days ago
Chuck Lorre ignited a feud with White House after a charity gala speech put Donald Trump on notice.
Lorre lamented that while he'd love to champion a "compassionate government," he instead feels compelled to "say a few words about that bloated orange piece of s--- in the White House."
A spokesperson for the White House responded, encouraging Lorre to "immediately seek psychiatric help to treat his severe case of Trump Derangement Syndrome."
Add Chuck Lorre to the overstuffed rolodex of Hollywood legends who have personal beef with Donald Trump.
The creator of such modern classics as The Big Bang Theory and Two and a Half Men took no prisoners in his acceptance speech after winning the Founders Award at a Project Angel Food fundraiser in Los Angeles on Sept. 26. "Sure, I'd love to stand here and talk about my deep yearning for a more compassionate government, one that prioritizes the health and welfare of its citizens," he lamented. "But the burden of my profession demands that I take this opportunity to say a few words about that bloated orange piece of s--- in the White House" (per The Daily Beast).
#lorre #speech #compassionate
Lorre lamented that while he'd love to champion a "compassionate government," he instead feels compelled to "say a few words about that bloated orange piece of s--- in the White House."
A spokesperson for the White House responded, encouraging Lorre to "immediately seek psychiatric help to treat his severe case of Trump Derangement Syndrome."
Add Chuck Lorre to the overstuffed rolodex of Hollywood legends who have personal beef with Donald Trump.
The creator of such modern classics as The Big Bang Theory and Two and a Half Men took no prisoners in his acceptance speech after winning the Founders Award at a Project Angel Food fundraiser in Los Angeles on Sept. 26. "Sure, I'd love to stand here and talk about my deep yearning for a more compassionate government, one that prioritizes the health and welfare of its citizens," he lamented. "But the burden of my profession demands that I take this opportunity to say a few words about that bloated orange piece of s--- in the White House" (per The Daily Beast).
#lorre #speech #compassionate
25 days ago
Science educator Bill Nye the Science Guy has been teaching Millennials all about science for their entire lives. At 70, he's still doing it.
Nye recently spoke at the Clinton Global Initiative 2026 Annual Meeting in New York City. While there, attendee Dr. Trisha Pasricha, MD, MPH, shared a video of Nye on TikTok that's gone viral. In it, Nye pulled out a physical copy of the U.S. Constitution while offering the audience an encouraging message about science.
"Bill Nye just pulled out the Constitution—and the crowd erupted," she wrote in the video's overlay, adding in the caption: "BillNye, the gentleman and scholar that you are."
In the video, Nye is participating in a panel discussion.
"I have a copy of the U.S. Constitution, which some of you may know is now available in paperback," he quips. "Say what you will about the U.S., say what you will about the Founding Fathers, the guys who wrote it. You could have mixed feelings about them. But Article 1, Section 8, Clause 8 of the U.S. Constitution [states]: 'The role of Congress is to promote the progress of science and useful arts.'"
#wrote
Nye recently spoke at the Clinton Global Initiative 2026 Annual Meeting in New York City. While there, attendee Dr. Trisha Pasricha, MD, MPH, shared a video of Nye on TikTok that's gone viral. In it, Nye pulled out a physical copy of the U.S. Constitution while offering the audience an encouraging message about science.
"Bill Nye just pulled out the Constitution—and the crowd erupted," she wrote in the video's overlay, adding in the caption: "BillNye, the gentleman and scholar that you are."
In the video, Nye is participating in a panel discussion.
"I have a copy of the U.S. Constitution, which some of you may know is now available in paperback," he quips. "Say what you will about the U.S., say what you will about the Founding Fathers, the guys who wrote it. You could have mixed feelings about them. But Article 1, Section 8, Clause 8 of the U.S. Constitution [states]: 'The role of Congress is to promote the progress of science and useful arts.'"
#wrote
26 days ago
Popular Twitch streamer Kai Cenat broke his silence on allegations made by fellow streamer Reggie Travers.
The claims center on 17-year-old QuVonn RaKai Linder, known online as RaKai, who is a frequent collaborator with Cenat. Travers alleged in a YouTube video on Sep. 27 that Cenat is ignoring ***** ual abuse Linder has faced in their inner circle. "Kai, you wrong as ***** , 'cause you know somebody took advantage of RaKai," Travers said, referencing the young streamer.
Travers escalated the allegations during a Sep. 30 Instagram livestream, calling Cenat a "pedophile." "He been grooming RaKai," Travers added in the clip, alleging that Cenat has been encouraging RaKai to do ***** ***** ual acts "for clout."
Cenat, 24, who is the seventh-most-subscribed person on Twitch with over 21.9 million followers, officially addressed the allegations on a livestream on Sep. 30. "Tomorrow, when you wake up, call the cops. Call the cops and show them evidence because guess what? I am calling the cops!" he said on air, addressing Travers. "I'm suing you, bro!"
"I still have sympathy for you because I know you're not yourself, bro. But it's gone too far," Cenat added.
#twitch #linder
The claims center on 17-year-old QuVonn RaKai Linder, known online as RaKai, who is a frequent collaborator with Cenat. Travers alleged in a YouTube video on Sep. 27 that Cenat is ignoring ***** ual abuse Linder has faced in their inner circle. "Kai, you wrong as ***** , 'cause you know somebody took advantage of RaKai," Travers said, referencing the young streamer.
Travers escalated the allegations during a Sep. 30 Instagram livestream, calling Cenat a "pedophile." "He been grooming RaKai," Travers added in the clip, alleging that Cenat has been encouraging RaKai to do ***** ***** ual acts "for clout."
Cenat, 24, who is the seventh-most-subscribed person on Twitch with over 21.9 million followers, officially addressed the allegations on a livestream on Sep. 30. "Tomorrow, when you wake up, call the cops. Call the cops and show them evidence because guess what? I am calling the cops!" he said on air, addressing Travers. "I'm suing you, bro!"
"I still have sympathy for you because I know you're not yourself, bro. But it's gone too far," Cenat added.
#twitch #linder
26 days ago
Cenat challenged Reggie to take any evidence to law enforcement, while RaKai separately denied claims made about his childhood.
Kai Cenat says he plans to sue fellow streamer Reggie after the creator escalated his allegations involving RaKai during a Sept. 30 livestream. The threat follows Reggie's earlier claims involving Cenat while discussing his own alleged childhood abuse. RaKai, who participated in Cenat's Streamer University, has since denied Reggie's claims about him.
The Times of India reported that during an Instagram Live ******* led "Truth," Reggie accused Cenat of grooming RaKai and encouraging inappropriate behavior for fame and clout. He also made other serious accusations against Cenat. The claims remain unverified, and Reggie did not publicly provide evidence establishing them.
Cenat responded during a Sept. 30 livestream by challenging Reggie to take whatever evidence he says he has to law enforcement. "Call the cops and show them evidence," Cenat said, before adding that he planned to call police himself and sue Reggie.
Cenat said he had not originally intended to pursue a lawsuit but changed his position after the latest allegations. He argued that the accusations were affecting his reputation, his family and his future, and accused Reggie of taking claims circulating in TikTok comments and presenting them as his own.
#reggie #call #take #enforcement
Kai Cenat says he plans to sue fellow streamer Reggie after the creator escalated his allegations involving RaKai during a Sept. 30 livestream. The threat follows Reggie's earlier claims involving Cenat while discussing his own alleged childhood abuse. RaKai, who participated in Cenat's Streamer University, has since denied Reggie's claims about him.
The Times of India reported that during an Instagram Live ******* led "Truth," Reggie accused Cenat of grooming RaKai and encouraging inappropriate behavior for fame and clout. He also made other serious accusations against Cenat. The claims remain unverified, and Reggie did not publicly provide evidence establishing them.
Cenat responded during a Sept. 30 livestream by challenging Reggie to take whatever evidence he says he has to law enforcement. "Call the cops and show them evidence," Cenat said, before adding that he planned to call police himself and sue Reggie.
Cenat said he had not originally intended to pursue a lawsuit but changed his position after the latest allegations. He argued that the accusations were affecting his reputation, his family and his future, and accused Reggie of taking claims circulating in TikTok comments and presenting them as his own.
#reggie #call #take #enforcement
1 month ago
On September 14, Evercore ISI raised its price target for Netflix, Inc. (NASDAQ:NFLX) from $100 to $110 while maintaining its Outperform rating. The research firm rolled its valuation framework forward to 2028 and applied a multiple of 25 times its 2028 EPS estimate.
The new price target represents more than 40% upside from the share price of $76.41 as of September 16. However, the stock has declined about 16% year-to-date and remains well below its 52-week high of $124.86.
Evercore ISI conducted its 58th quarterly US survey and 12th semi-annual ****** an survey on Netflix, Inc. (NASDAQ:NFLX), which showed multi-year high penetration of 63% in the US and a record-high 22% penetration in ****** an.
Japan also showed strong subscriber engagement as 58% of subscribers said they were slightly or not at all likely to cancel. Subscriber satisfaction in ****** an also reached 67%.
The company's new ads plan also showed encouraging signs in ****** an. About 66% of new ads plan subscribers were either former Netflix users or people who were new to Netflix.
#high
The new price target represents more than 40% upside from the share price of $76.41 as of September 16. However, the stock has declined about 16% year-to-date and remains well below its 52-week high of $124.86.
Evercore ISI conducted its 58th quarterly US survey and 12th semi-annual ****** an survey on Netflix, Inc. (NASDAQ:NFLX), which showed multi-year high penetration of 63% in the US and a record-high 22% penetration in ****** an.
Japan also showed strong subscriber engagement as 58% of subscribers said they were slightly or not at all likely to cancel. Subscriber satisfaction in ****** an also reached 67%.
The company's new ads plan also showed encouraging signs in ****** an. About 66% of new ads plan subscribers were either former Netflix users or people who were new to Netflix.
#high
1 month ago
On September 14, Evercore ISI raised its price target for Netflix, Inc. (NASDAQ:NFLX) from $100 to $110 while maintaining its Outperform rating. The research firm rolled its valuation framework forward to 2028 and applied a multiple of 25 times its 2028 EPS estimate.
The new price target represents more than 40% upside from the share price of $76.41 as of September 16. However, the stock has declined about 16% year-to-date and remains well below its 52-week high of $124.86.
Evercore ISI conducted its 58th quarterly US survey and 12th semi-annual **** an survey on Netflix, Inc. (NASDAQ:NFLX), which showed multi-year high penetration of 63% in the US and a record-high 22% penetration in **** an.
Japan also showed strong subscriber engagement as 58% of subscribers said they were slightly or not at all likely to cancel. Subscriber satisfaction in **** an also reached 67%.
The company's new ads plan also showed encouraging signs in **** an. About 66% of new ads plan subscribers were either former Netflix users or people who were new to Netflix.
#netflix #price #september #evercore
The new price target represents more than 40% upside from the share price of $76.41 as of September 16. However, the stock has declined about 16% year-to-date and remains well below its 52-week high of $124.86.
Evercore ISI conducted its 58th quarterly US survey and 12th semi-annual **** an survey on Netflix, Inc. (NASDAQ:NFLX), which showed multi-year high penetration of 63% in the US and a record-high 22% penetration in **** an.
Japan also showed strong subscriber engagement as 58% of subscribers said they were slightly or not at all likely to cancel. Subscriber satisfaction in **** an also reached 67%.
The company's new ads plan also showed encouraging signs in **** an. About 66% of new ads plan subscribers were either former Netflix users or people who were new to Netflix.
#netflix #price #september #evercore
1 month ago
On September 10, 2026, Copart, Inc. (NASDAQ:CPRT) reported fourth-quarter results for the period ended July 31, 2026, and used the call to announce an all-cash acquisition of digital auto marketplace ACV Auctions. Revenue grew 2.4% to $1.2 billion, but gross profit fell 5.5% to $481.4 million and net income dropped 17.4% to $327.4 million. Diluted EPS came in at $0.35 against $0.41 a year earlier.
Wall Street spent the following days separating the deal from the quarter.
Barrington's Gary Prestopino saw enough in the transaction to move off the sidelines, upgrading Copart, Inc. (NASDAQ:CPRT) to Outperform from Market Perform with a $40 target. His argument is that combining Copart's physical network with ACV's digital marketplace, at an implied equity value of $1.9 billion or $10.50 per share in cash, creates an end-to-end remarketing platform and opens a new growth vector in dealer-to-dealer and commercial vehicle auctions.
JPMorgan's Jash Patwa had already upgraded Copart, Inc. (NASDAQ:CPRT) to Overweight from Neutral ahead of the print, raising his target to $40 from $32 on encouraging salvage industry channel checks, web scraping data showing Copart gaining share with a carrier across several states, and a collision cycle he sees turning more favorable as insurance penetration recovers.
Freedom Broker, which trimmed its target to $36 from $39 while keeping a Buy rating, called the report mixed but framed the ACV move as a strong pivot toward digital marketplace expansion.
#NASDAQ #cprt #auctions
Wall Street spent the following days separating the deal from the quarter.
Barrington's Gary Prestopino saw enough in the transaction to move off the sidelines, upgrading Copart, Inc. (NASDAQ:CPRT) to Outperform from Market Perform with a $40 target. His argument is that combining Copart's physical network with ACV's digital marketplace, at an implied equity value of $1.9 billion or $10.50 per share in cash, creates an end-to-end remarketing platform and opens a new growth vector in dealer-to-dealer and commercial vehicle auctions.
JPMorgan's Jash Patwa had already upgraded Copart, Inc. (NASDAQ:CPRT) to Overweight from Neutral ahead of the print, raising his target to $40 from $32 on encouraging salvage industry channel checks, web scraping data showing Copart gaining share with a carrier across several states, and a collision cycle he sees turning more favorable as insurance penetration recovers.
Freedom Broker, which trimmed its target to $36 from $39 while keeping a Buy rating, called the report mixed but framed the ACV move as a strong pivot toward digital marketplace expansion.
#NASDAQ #cprt #auctions
1 month ago
On September 2, 2026, Phreesia, Inc. (NYSE:PHR) reported second-quarter fiscal 2027 results for the period ended July 31, 2026. Revenue rose 10% to $129.5 million and adjusted EBITDA climbed to $32.9 million from $22.1 million a year earlier, a 25% margin. Net income reached $1.9 million, marking the company's fifth consecutive quarter of profitability. Management reaffirmed full-year revenue guidance of $510 million to $520 million and adjusted EBITDA of $125 million to $135 million.
The disagreement on Wall Street is about what that reaffirmation actually signals.
Wells Fargo found the highlight in Network Solutions, which grew 9% year-over-year, and pointed to the ProviderConnect pilot delivering a 4% prescription lift in a GLP-1 campaign that management says is generating follow-on business; the firm raised its target on Phreesia, Inc. (NYSE:PHR) to $10 from $9 while holding an Equal Weight rating.
DA Davidson stayed at Buy despite trimming its target on Phreesia, Inc. (NYSE:PHR) to $13 from $14, arguing the stock sold off on a reiterated guide even though network solutions activity is tracking more encouragingly than the prior outlook and AccessOne is opening a growing opportunity in alternative consumer payment options.
Baird ******* yst Joe Vruwink lifted his target to $11 from $10 at Neutral after updating his model.
#million #solutions
The disagreement on Wall Street is about what that reaffirmation actually signals.
Wells Fargo found the highlight in Network Solutions, which grew 9% year-over-year, and pointed to the ProviderConnect pilot delivering a 4% prescription lift in a GLP-1 campaign that management says is generating follow-on business; the firm raised its target on Phreesia, Inc. (NYSE:PHR) to $10 from $9 while holding an Equal Weight rating.
DA Davidson stayed at Buy despite trimming its target on Phreesia, Inc. (NYSE:PHR) to $13 from $14, arguing the stock sold off on a reiterated guide even though network solutions activity is tracking more encouragingly than the prior outlook and AccessOne is opening a growing opportunity in alternative consumer payment options.
Baird ******* yst Joe Vruwink lifted his target to $11 from $10 at Neutral after updating his model.
#million #solutions
1 month ago
Johnson & Johnson (JNJ) has been a rewarding stock to hold, up about 53% over the past year against about 17% for the S&P 500. The change worth noticing over that stretch is quieter than the price. Management said sales still rose 5.6% despite a STELARA drag of about 460 basis points. Management is encouraging investors to evaluate the company's underlying momentum by presenting growth rates that exclude STELARA alongside its reported figures.
A year and a half ago, that drag was the headline. Management's own framing of the first quarter of 2025 noted an approximate 810 basis point headwind on Innovative Medicine sales.
By the second quarter of 2026, that segment-level drag remained heavy at roughly 760 basis points (or about 460 basis points across the total enterprise), yet management's emphasis shifted to highlighting double-digit operational growth excluding STELARA
The exclusion is not a rounding adjustment. STELARA sales fell 55.7% in the second quarter of 2026, and management put that drag at about 460 basis points of the whole company's 5.6% operational sales growth.
Two products show what the replacement looks like. TREMFYA booked $2 billion of sales in the second quarter of 2026, up over 70%, and management says ulcerative colitis and Crohn's disease are the major drivers of that growth. ICOTYDE, a recently launched once-daily pill for psoriasis, is the second, which leadership has highlighted as a key pipeline priority for the immunology business.
#sales #basis #drag #quarter
A year and a half ago, that drag was the headline. Management's own framing of the first quarter of 2025 noted an approximate 810 basis point headwind on Innovative Medicine sales.
By the second quarter of 2026, that segment-level drag remained heavy at roughly 760 basis points (or about 460 basis points across the total enterprise), yet management's emphasis shifted to highlighting double-digit operational growth excluding STELARA
The exclusion is not a rounding adjustment. STELARA sales fell 55.7% in the second quarter of 2026, and management put that drag at about 460 basis points of the whole company's 5.6% operational sales growth.
Two products show what the replacement looks like. TREMFYA booked $2 billion of sales in the second quarter of 2026, up over 70%, and management says ulcerative colitis and Crohn's disease are the major drivers of that growth. ICOTYDE, a recently launched once-daily pill for psoriasis, is the second, which leadership has highlighted as a key pipeline priority for the immunology business.
#sales #basis #drag #quarter
1 month ago
On September 9, American Eagle Outfitters Inc. (NYSE:AEO) revealed results for its fiscal 2026 second quarter. The company achieved an 8% year-over-year topline growth with net revenue figures of $1.38 billion. The second quarter operating profit jumped up to $211 million compared to $103 million during the same period last year. As a result, diluted earnings per share for the quarter stood at $0.79 in comparison with $0.45 for Q2 FY25. This led to a $21 million distribution to shareholders with a dividend payout of $0.125 per share.
Africa Studio/Shutterstock.com
A resilient performance during the second quarter was primarily driven by robust momentum within the Aerie sub-brand and OFFLINE collection. There was a 6% year-over-year growth in company-wide comparable sales, whereas the Aerie's comparable sales picked up by 19%. Total gross profit for the quarter reached $672 million, which shows a 34% increase against $500 million for Q2 FY25. This pushed Q2 gross margins to 48.7%, a jump of 980 basis points relative to the previous year's quarter, despite 330 basis points deleveraging across the merchandise margins. Compared to an 8% operating margin in Q2 FY25, the company posted 15.3% margin in the recent period.
Even with a slight dip in comparable sales, the American Eagle brand also exhibited some encouraging signs. It posted sequential gains from the previous quarter, which marks the fourth consecutive quarter of expansion across menswear.
Results for the reported period were bolstered by $196 million in International Emergency Economic Powers Act (IEEPA) tariff refunds, which also included interest payments. This resulted in an additional $35 million in incentive compensation set aside by the company, which affected both gross profit and SG&A. After taking these additional expenses into consideration, the overall operating income gains related to tariff refunds amounted to $161 million.
#comparable
Africa Studio/Shutterstock.com
A resilient performance during the second quarter was primarily driven by robust momentum within the Aerie sub-brand and OFFLINE collection. There was a 6% year-over-year growth in company-wide comparable sales, whereas the Aerie's comparable sales picked up by 19%. Total gross profit for the quarter reached $672 million, which shows a 34% increase against $500 million for Q2 FY25. This pushed Q2 gross margins to 48.7%, a jump of 980 basis points relative to the previous year's quarter, despite 330 basis points deleveraging across the merchandise margins. Compared to an 8% operating margin in Q2 FY25, the company posted 15.3% margin in the recent period.
Even with a slight dip in comparable sales, the American Eagle brand also exhibited some encouraging signs. It posted sequential gains from the previous quarter, which marks the fourth consecutive quarter of expansion across menswear.
Results for the reported period were bolstered by $196 million in International Emergency Economic Powers Act (IEEPA) tariff refunds, which also included interest payments. This resulted in an additional $35 million in incentive compensation set aside by the company, which affected both gross profit and SG&A. After taking these additional expenses into consideration, the overall operating income gains related to tariff refunds amounted to $161 million.
#comparable
1 month ago
On September 8, United Natural Foods Inc. (NYSE:UNFI) announced its fourth quarter and full FY26 results. For the final quarter, the company posted an adjusted EBITDA of $172 million, which grew 48.3% compared to Q4 FY25. United's fourth quarter adjusted EPS of $0.69 took a sharp turn relative to a $0.11 adjusted loss per share for the same period last year. Cash flow from operating activities for the quarter stood at $197 million, along with free cash flow of $80 million.
Nejron Photo/Shutterstock.com
Amid a favorable customer mix and network optimizations, United delivered Q4 gross profit of $1,050 million, increasing marginally by 1.9% from the same period last year. This led to a gross margin of 13.7%, compared to 13.4% recorded in Q4 FY25. Cost-saving initiatives, which included efficient productivity through distribution centers and network optimizations, translated into lower operating expenses on a year-over-year basis. It helped United jump from an $87 million net loss for Q4 FY25 to a net income of $35 million during the recently concluded quarter.
For the complete fiscal year, the company delivered an adjusted EBITDA of $701 million, showcasing a 27% growth compared to FY25. Full-year adjusted EPS also climbed from $0.71 last year to $2.65. United generated FY26 operating cash flow of $540 million and free cash flow of $323 million.
Several encouraging operational developments took place during the fourth quarter. United initiated onboarding additional business from its existing customer base, as well as the new ones. Topline impact of such additions will be seen during FY27, once the broader optimization initiatives have cycled through. For its Lean Daily Management (LDM) program, the company concluded a preliminary rollout covering 44 distribution centers. This resulted in year-over-year enhancement in fill rates, throughput, and on-time deliveries, for four consecutive quarters.
#cash #flow #fourth #company
Nejron Photo/Shutterstock.com
Amid a favorable customer mix and network optimizations, United delivered Q4 gross profit of $1,050 million, increasing marginally by 1.9% from the same period last year. This led to a gross margin of 13.7%, compared to 13.4% recorded in Q4 FY25. Cost-saving initiatives, which included efficient productivity through distribution centers and network optimizations, translated into lower operating expenses on a year-over-year basis. It helped United jump from an $87 million net loss for Q4 FY25 to a net income of $35 million during the recently concluded quarter.
For the complete fiscal year, the company delivered an adjusted EBITDA of $701 million, showcasing a 27% growth compared to FY25. Full-year adjusted EPS also climbed from $0.71 last year to $2.65. United generated FY26 operating cash flow of $540 million and free cash flow of $323 million.
Several encouraging operational developments took place during the fourth quarter. United initiated onboarding additional business from its existing customer base, as well as the new ones. Topline impact of such additions will be seen during FY27, once the broader optimization initiatives have cycled through. For its Lean Daily Management (LDM) program, the company concluded a preliminary rollout covering 44 distribution centers. This resulted in year-over-year enhancement in fill rates, throughput, and on-time deliveries, for four consecutive quarters.
#cash #flow #fourth #company
1 month ago
On September 10, Imperial Petroleum Inc. (NASDAQ:IMPP), a company involved in seaborne transportation of crude oil, dry bulk, and petroleum products, released its second quarter results. With a topline figure of $87.1 million, the company delivered record quarterly revenue, which also resulted in 139.9% year-over-year growth. Imperial's adjusted EBITDA for the second quarter stood at $41.7 million, while the Q2 adjusted net income of $35.3 million exhibited around 163% growth in comparison with Q2 FY25.
Ralf Gosch/Shutterstock.com
Several factors contributed to the second quarter topline growth. A 6.9 vessel rise in the company's average fleet size was the primary growth enabler. Other factors include encouraging dynamics across the drybulk segment, and higher rates for both drybulk and tankers amid the geopolitical uncertainties. Operating income for the quarter jumped to a near-record level of $33.4 million, which translates into a 307.3% growth relative to Q2 FY25. Imperial posted an adjusted EPS of $0.76 for the reported quarter, which almost doubled compared to the same quarter a year prior.
At the back of efficient fleet management, management remained focus on strengthening its financial position. The company ended the quarter with no debt, and its liquidity position also remained resilient. Cash and cash equivalents, including time deposits, increased from $179.1 million at the end of 2025 to $245.2 million as of June 30, 2026. The company added that its cash base had increased further to approximately $260 million as of the September 10 results release.
Certain areas of weakness warrant a closer examination. During the reported quarter, fleet operational utilization went down from 83.1% in prior year's second quarter to 73.5%. There was a substantial increase in some of the underlying operating expenses. For instance, the vessel operating expense stood at $14.4 million compared to $8.4 million during Q2 FY25. This $6 million rise can be attributed to Imperial's larger fleet size. Similarly, the voyage expenses also jumped from $10.7 million in last year's Q2 to $22.1 million for Q2 FY26. The incremental voyage expenses stemmed from higher bunkers' rates, as well as a 58.4% jump in spot days.
#fleet
Ralf Gosch/Shutterstock.com
Several factors contributed to the second quarter topline growth. A 6.9 vessel rise in the company's average fleet size was the primary growth enabler. Other factors include encouraging dynamics across the drybulk segment, and higher rates for both drybulk and tankers amid the geopolitical uncertainties. Operating income for the quarter jumped to a near-record level of $33.4 million, which translates into a 307.3% growth relative to Q2 FY25. Imperial posted an adjusted EPS of $0.76 for the reported quarter, which almost doubled compared to the same quarter a year prior.
At the back of efficient fleet management, management remained focus on strengthening its financial position. The company ended the quarter with no debt, and its liquidity position also remained resilient. Cash and cash equivalents, including time deposits, increased from $179.1 million at the end of 2025 to $245.2 million as of June 30, 2026. The company added that its cash base had increased further to approximately $260 million as of the September 10 results release.
Certain areas of weakness warrant a closer examination. During the reported quarter, fleet operational utilization went down from 83.1% in prior year's second quarter to 73.5%. There was a substantial increase in some of the underlying operating expenses. For instance, the vessel operating expense stood at $14.4 million compared to $8.4 million during Q2 FY25. This $6 million rise can be attributed to Imperial's larger fleet size. Similarly, the voyage expenses also jumped from $10.7 million in last year's Q2 to $22.1 million for Q2 FY26. The incremental voyage expenses stemmed from higher bunkers' rates, as well as a 58.4% jump in spot days.
#fleet
1 month ago
The Republican speaker of the House, Mike Johnson, announced on Wednesday that he would again cancel votes scheduled for Thursday, sending lawmakers home one day early ahead of the midterm election recess.
The latest change to the legislative schedule means House members will avoid voting on Republican Thomas Massie's resolution to impeach the defense secretary, Pete Hegseth, and comes amid a frenzied attempt to propose legislation on artificial intelligence.
It's the latest round of cancellations at the hands of Johnson, who had already cut the pre-election session short by two weeks. Democrats have reacted angrily, encouraging Johnson to keep lawmakers on Capitol Hill before the midterm recess beginning on Friday.
Related: More Republicans are turning on Iran war as midterms come into view
"I think it shows the cowardice of the Republican party. They are canceling votes to do business for the American people because they are afraid that that impeachment resolution of Pete Hegseth would pass on a bipartisan basis," the Democratic representative Pramila Jayapal told MediasTouch.
#votes #election
The latest change to the legislative schedule means House members will avoid voting on Republican Thomas Massie's resolution to impeach the defense secretary, Pete Hegseth, and comes amid a frenzied attempt to propose legislation on artificial intelligence.
It's the latest round of cancellations at the hands of Johnson, who had already cut the pre-election session short by two weeks. Democrats have reacted angrily, encouraging Johnson to keep lawmakers on Capitol Hill before the midterm recess beginning on Friday.
Related: More Republicans are turning on Iran war as midterms come into view
"I think it shows the cowardice of the Republican party. They are canceling votes to do business for the American people because they are afraid that that impeachment resolution of Pete Hegseth would pass on a bipartisan basis," the Democratic representative Pramila Jayapal told MediasTouch.
#votes #election
1 month ago
The Seattle Seahawks issued a cryptic but encouraging update regarding the health of injured quarterback Sam Darnold Monday.
While the precise nature of his injury remains ambiguous, the update points to Darnold returning to the field sooner than later.
Per the Seahawks, Darnold sustained a "very unique soft-tissue." The injury is actually to a glute muscle rather than his hip and is considered "short-term."
Here's the full statement released by the Seahawks Monday evening:
"Darnold, who was injured on a sack that ended Seattle's first drive, has a very unique soft-tissue injury, but the hip joint is unaffected by the injury. While there is no firm timeline on Darnold's return, it is considered a short-term injury."
#unique #soft #tissue
While the precise nature of his injury remains ambiguous, the update points to Darnold returning to the field sooner than later.
Per the Seahawks, Darnold sustained a "very unique soft-tissue." The injury is actually to a glute muscle rather than his hip and is considered "short-term."
Here's the full statement released by the Seahawks Monday evening:
"Darnold, who was injured on a sack that ended Seattle's first drive, has a very unique soft-tissue injury, but the hip joint is unaffected by the injury. While there is no firm timeline on Darnold's return, it is considered a short-term injury."
#unique #soft #tissue
1 month ago
The Detroit Lions will be without Isiah Pacheco considerably longer than originally hoped.
Dan Campbell revealed Monday that the veteran running back underwent surgery and will be "out awhile." Campbell did not specify whether the procedure addressed Pacheco's knee or back, the two injuries that derailed his first training camp in Detroit.
That is a rough turn for a player the Lions signed in March expecting him to provide a physical complement to Jahmyr Gibbs. Pacheco arrived in Detroit after four seasons with Kansas City, where he rushed for 2,537 yards and won two Super Bowls.
Pacheco initially suffered a sprained MCL during training camp. At the time, Campbell believed the Lions had avoided a major problem, something we covered when Detroit first received encouraging news on the injury.
The knee later improved, but a back issue emerged late in camp and became the larger concern. Detroit ultimately placed Pacheco on injured reserve before Week 1, guaranteeing he would miss at least the first four games.
#detroit #campbell #four
Dan Campbell revealed Monday that the veteran running back underwent surgery and will be "out awhile." Campbell did not specify whether the procedure addressed Pacheco's knee or back, the two injuries that derailed his first training camp in Detroit.
That is a rough turn for a player the Lions signed in March expecting him to provide a physical complement to Jahmyr Gibbs. Pacheco arrived in Detroit after four seasons with Kansas City, where he rushed for 2,537 yards and won two Super Bowls.
Pacheco initially suffered a sprained MCL during training camp. At the time, Campbell believed the Lions had avoided a major problem, something we covered when Detroit first received encouraging news on the injury.
The knee later improved, but a back issue emerged late in camp and became the larger concern. Detroit ultimately placed Pacheco on injured reserve before Week 1, guaranteeing he would miss at least the first four games.
#detroit #campbell #four
1 month ago
Panthers news: Jalen **** er injury update is good news after Week 1 appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
Jalen **** er gave Carolina Panthers fans a scare after his monster Week 1 performance, but his initial injury update sounds encouraging.
Coker told reporters Monday that he rolled his ankle during the first quarter of Sunday's 59-37 loss to the Chicago Bears but expects to practice Wednesday.
That's tremendous news considering **** er somehow played through the injury and proceeded to torch Chicago's secondary.
The third-year receiver caught eight of his nine targets for a career-high 138 yards and two touchdowns, including a 51-yard score from Bryce Young. It was also the first multi-touchdown performance of **** er's career.
#update
Jalen **** er gave Carolina Panthers fans a scare after his monster Week 1 performance, but his initial injury update sounds encouraging.
Coker told reporters Monday that he rolled his ankle during the first quarter of Sunday's 59-37 loss to the Chicago Bears but expects to practice Wednesday.
That's tremendous news considering **** er somehow played through the injury and proceeded to torch Chicago's secondary.
The third-year receiver caught eight of his nine targets for a career-high 138 yards and two touchdowns, including a 51-yard score from Bryce Young. It was also the first multi-touchdown performance of **** er's career.
#update
1 month ago
The Jacksonville Jaguars received a scare involving one of their most important offensive players during Sunday's NFL Week 1 win over the Cleveland Browns. Brian Thomas Jr. left the game in the second quarter with a shoulder injury and initially was listed as questionable to return, creating immediate concern for a Jacksonville offense that had already jumped out to a big lead.
Fortunately, the latest update is much more encouraging than it initially appeared, and the Jaguars came away with a 34-10 victory over Cleveland.
MORE: 3 NFL teams that should be worried after Week 1
Jacksonville Jaguars wide receiver Brian Thomas Jr. (7) catches a pass during the first day of NFL Training Camp at the Miller Electric Center on Wednesday, July 29, 2026, in Jacksonville, Fla.
Thomas headed to the locker room with Jacksonville's medical staff after apparently injuring his shoulder. The Jaguars announced that he was questionable to return, and he had already made an impact before leaving, catching all three of his targets for 40 yards.
#cleveland
Fortunately, the latest update is much more encouraging than it initially appeared, and the Jaguars came away with a 34-10 victory over Cleveland.
MORE: 3 NFL teams that should be worried after Week 1
Jacksonville Jaguars wide receiver Brian Thomas Jr. (7) catches a pass during the first day of NFL Training Camp at the Miller Electric Center on Wednesday, July 29, 2026, in Jacksonville, Fla.
Thomas headed to the locker room with Jacksonville's medical staff after apparently injuring his shoulder. The Jaguars announced that he was questionable to return, and he had already made an impact before leaving, catching all three of his targets for 40 yards.
#cleveland
1 month ago
Dodgers news: Kris Bubic joining LA as playoffs draw near, but there's a catch appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
The Los Angeles Dodgers acquired left-handed pitcher Kris Bubic before the 2026 MLB trade deadline. The former All-Star has yet to make has Dodgers debut. Bubic has been recovering from elbow and shoulder injury concerns. According to Maddie Lee of the Los Angeles Times, Bubic is going to join the Dodgers on Monday. However, he is not being activated from the injured list yet.
"Kris Bubic is set to join the Dodgers in Cincinnati, per sources. But because he made a rehab appearance yesterday, he isn't expected to be activated right away," Lee reported.
The fact that he is joining the team is encouraging. It seems as if he could be activated fairly soon, even if the move doesn't happen Monday.
Watch sports LIVE with fuboTV (free trial)
#joining #preferred
The Los Angeles Dodgers acquired left-handed pitcher Kris Bubic before the 2026 MLB trade deadline. The former All-Star has yet to make has Dodgers debut. Bubic has been recovering from elbow and shoulder injury concerns. According to Maddie Lee of the Los Angeles Times, Bubic is going to join the Dodgers on Monday. However, he is not being activated from the injured list yet.
"Kris Bubic is set to join the Dodgers in Cincinnati, per sources. But because he made a rehab appearance yesterday, he isn't expected to be activated right away," Lee reported.
The fact that he is joining the team is encouraging. It seems as if he could be activated fairly soon, even if the move doesn't happen Monday.
Watch sports LIVE with fuboTV (free trial)
#joining #preferred
1 month ago
Vale S.A. (NYSE:VALE) is considering making its debut in China's domestic bond market as soon as this year, with CFO Marcelo Bacci saying the company is preparing for a potential Panda bond issuance. The move would be strategically significant because China accounts for roughly half of Vale's revenue, making renminbi financing a natural extension of its relationship with its largest market. Bloomberg reported that Vale is still ****** sing the market, including whether it can obtain a maturity longer than the typical two-, three-, or five-year terms available to international issuers.
The timing is also favorable for Vale because China's Panda bond market is expanding rapidly. Reuters reported that foreign issuers have increasingly turned to Asian bond markets to diversify funding sources, while Chinese yuan bond issuance has reached record levels in 2026. For Vale S.A. (NYSE:VALE), the potential transaction therefore looks less like a necessity for raising capital and more like an effort to diversify its investor base, potentially lower funding costs, and build a longer-term financing relationship with Chinese investors.
The strongest bullish argument is that Vale S.A. (NYSE:VALE) could potentially lower and diversify its cost of capital by accessing a large pool of Chinese investors at a time when renminbi funding remains relatively inexpensive. Reuters noted that Chinese onshore and offshore yuan bond markets have experienced record issuance this year, with foreign borrowers increasingly using these markets to diversify away from traditional funding currencies. If Vale can achieve competitive pricing, a Panda bond could provide an additional funding channel alongside its established dollar financing, reducing its dependence on a single market.
The move could also create a better natural match between Vale's revenues and its financing currency. Because China represents approximately half of Vale's revenue, raising at least some debt in renminbi could provide a degree of currency alignment with its Chinese business exposure. More importantly, establishing itself as a repeat issuer could strengthen Vale's relationships with Chinese banks and institutional investors, potentially giving it access to another source of capital when global dollar markets become less attractive.
There is also a broader strategic benefit. China is actively expanding the Panda bond market and encouraging international companies to use it. Official Chinese data showed that more than 160 billion yuan of Panda bonds were issued during the first half of 2026, up 69% year over year, demonstrating that the market is becoming more established and liquid. Vale entering this market could therefore position the company early in a growing financing ecosystem rather than waiting until it becomes more crowded.
#chinese #bond #panda #China
The timing is also favorable for Vale because China's Panda bond market is expanding rapidly. Reuters reported that foreign issuers have increasingly turned to Asian bond markets to diversify funding sources, while Chinese yuan bond issuance has reached record levels in 2026. For Vale S.A. (NYSE:VALE), the potential transaction therefore looks less like a necessity for raising capital and more like an effort to diversify its investor base, potentially lower funding costs, and build a longer-term financing relationship with Chinese investors.
The strongest bullish argument is that Vale S.A. (NYSE:VALE) could potentially lower and diversify its cost of capital by accessing a large pool of Chinese investors at a time when renminbi funding remains relatively inexpensive. Reuters noted that Chinese onshore and offshore yuan bond markets have experienced record issuance this year, with foreign borrowers increasingly using these markets to diversify away from traditional funding currencies. If Vale can achieve competitive pricing, a Panda bond could provide an additional funding channel alongside its established dollar financing, reducing its dependence on a single market.
The move could also create a better natural match between Vale's revenues and its financing currency. Because China represents approximately half of Vale's revenue, raising at least some debt in renminbi could provide a degree of currency alignment with its Chinese business exposure. More importantly, establishing itself as a repeat issuer could strengthen Vale's relationships with Chinese banks and institutional investors, potentially giving it access to another source of capital when global dollar markets become less attractive.
There is also a broader strategic benefit. China is actively expanding the Panda bond market and encouraging international companies to use it. Official Chinese data showed that more than 160 billion yuan of Panda bonds were issued during the first half of 2026, up 69% year over year, demonstrating that the market is becoming more established and liquid. Vale entering this market could therefore position the company early in a growing financing ecosystem rather than waiting until it becomes more crowded.
#chinese #bond #panda #China
1 month ago
The Cooper Companies, Inc. (NASDAQ:COO) cut its fiscal 2026 profit and revenue forecasts after weaker-than-expected demand for contact lenses weighed on its CooperVision business. The company now expects adjusted earnings of $4.51–$4.55 per share, down from its previous forecast of $4.58–$4.66, while revenue guidance was reduced to $4.23–$4.25 billion from $4.29–$4.32 billion. Third-quarter revenue came in at $1.07 billion, below Wall Street's $1.10 billion estimate, although adjusted EPS of $1.15 beat expectations.
The weakness was concentrated in CooperVision, where revenue fell to $717 million. Cooper said a reduction in U.S. channel inventory hurt results and is expected to continue affecting the fourth quarter. At the same time, the company completed its strategic review and decided to retain CooperSurgical rather than sell the business.
The biggest bullish argument is that some of the current weakness may be temporary rather than a fundamental deterioration in the contact lens market. The Cooper Companies, Inc. (NASDAQ:COO) specifically pointed to U.S. channel inventory reductions, meaning part of the sales pressure reflects distributors and customers working through existing stock rather than consumers permanently abandoning contact lenses. If inventories normalize, CooperVision could see a recovery in sales growth.
Cooper also continues to have a strong position in the global contact lens market. The company is investing in new products, expanding CooperVision's sales and marketing organization and improving inventory and logistics operations. Its strategic review also identified opportunities to reduce costs and improve operational efficiency.
There are encouraging signs beneath the weak headline numbers. Adjusted third-quarter EPS still increased 4% year over year to $1.15, while free cash flow jumped 66% to $273 million. The Cooper Companies, Inc. (NASDAQ:COO) also increased its share-repurchase authorization from $2 billion to $3 billion, giving the company another way to support per-share earnings if the stock remains depressed.
#Companies #revenue #contact #coopervision
The weakness was concentrated in CooperVision, where revenue fell to $717 million. Cooper said a reduction in U.S. channel inventory hurt results and is expected to continue affecting the fourth quarter. At the same time, the company completed its strategic review and decided to retain CooperSurgical rather than sell the business.
The biggest bullish argument is that some of the current weakness may be temporary rather than a fundamental deterioration in the contact lens market. The Cooper Companies, Inc. (NASDAQ:COO) specifically pointed to U.S. channel inventory reductions, meaning part of the sales pressure reflects distributors and customers working through existing stock rather than consumers permanently abandoning contact lenses. If inventories normalize, CooperVision could see a recovery in sales growth.
Cooper also continues to have a strong position in the global contact lens market. The company is investing in new products, expanding CooperVision's sales and marketing organization and improving inventory and logistics operations. Its strategic review also identified opportunities to reduce costs and improve operational efficiency.
There are encouraging signs beneath the weak headline numbers. Adjusted third-quarter EPS still increased 4% year over year to $1.15, while free cash flow jumped 66% to $273 million. The Cooper Companies, Inc. (NASDAQ:COO) also increased its share-repurchase authorization from $2 billion to $3 billion, giving the company another way to support per-share earnings if the stock remains depressed.
#Companies #revenue #contact #coopervision
1 month ago
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) could be positioning itself for its next major phase of growth following its roughly $10 billion acquisition of Crinetics Pharmaceuticals. The deal gives the company immediate exposure to the endocrinology market and provides a new commercial platform beyond its established cystic fibrosis franchise.
On September 3, Citigroup **** yst Geoff Meacham highlighted the strategic importance of the Crinetics acquisition, arguing it could diversify Vertex's business while complementing its existing cystic fibrosis franchise and newer businesses in renal disease, hematology, and pain.
Through the transaction, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) gains access to Palsonify (paltusotine), an oral treatment for acromegaly that has already received regulatory approval in Europe. Paltusotine is also in Phase 3 development for carcinoid syndrome **** ociated with neuroendocrine tumors.
Palsonify is particularly important because it provides an immediate commercial revenue opportunity, rather than requiring the company to wait several years for an entirely new drug to reach the market.
Early uptake of Palsonify has been encouraging, supported by expanding physician adoption and improving reimbursement coverage. If that momentum continues, the drug could become an important contributor to Vertex's revenue growth.
#palsonify
On September 3, Citigroup **** yst Geoff Meacham highlighted the strategic importance of the Crinetics acquisition, arguing it could diversify Vertex's business while complementing its existing cystic fibrosis franchise and newer businesses in renal disease, hematology, and pain.
Through the transaction, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) gains access to Palsonify (paltusotine), an oral treatment for acromegaly that has already received regulatory approval in Europe. Paltusotine is also in Phase 3 development for carcinoid syndrome **** ociated with neuroendocrine tumors.
Palsonify is particularly important because it provides an immediate commercial revenue opportunity, rather than requiring the company to wait several years for an entirely new drug to reach the market.
Early uptake of Palsonify has been encouraging, supported by expanding physician adoption and improving reimbursement coverage. If that momentum continues, the drug could become an important contributor to Vertex's revenue growth.
#palsonify
1 month ago
Toward the end of the lightning round on September 8, when a caller inquired about AstraZeneca PLC (NYSE:AZN), Mad Money host Jim Cramer commented:
Alright, now, AstraZeneca reminds me of a company, it's not unlike Novartis. I'm a little nervous about it. It's been missing some of its trials. I don't think COPD is enough to change my mind… I am not going to put my money on AstraZeneca.
AstraZeneca PLC (NYSE:AZN) maintains a solid financial foundation supported by steady top-line growth and disciplined cost management. In its second-quarter report, the company generated total revenue of $15.38 billion, marking a 6.4% increase compared to the same period last year. Adjusted earnings per share reached $2.63, outperforming ****** yst consensus estimates.
The profitability was driven by strong global demand for core oncology and rare disease treatments, which successfully offset revenue headwinds from generic competition affecting older blockbusters like Farxiga and Brilinta. With a net margin hovering around 17.02% and management reiterating its full-year guidance for mid-to-high single-digit revenue growth along with low double-digit core EPS expansion, the core business continues to demonstrate commercial resilience.
The primary driver behind the skepticism could be based on tangible execution risks and regulatory hurdles that threaten AstraZeneca PLC's (NYSE:AZN) long-term top line. A significant blow to the rare disease division came when anselamimab failed to achieve statistical significance for the primary endpoint in the overall AL amyloidosis population in the Phase III CARES program, although AstraZeneca reported encouraging results in a prespecified subgroup of patients with kappa light-chain amyloidosis.
#management
Alright, now, AstraZeneca reminds me of a company, it's not unlike Novartis. I'm a little nervous about it. It's been missing some of its trials. I don't think COPD is enough to change my mind… I am not going to put my money on AstraZeneca.
AstraZeneca PLC (NYSE:AZN) maintains a solid financial foundation supported by steady top-line growth and disciplined cost management. In its second-quarter report, the company generated total revenue of $15.38 billion, marking a 6.4% increase compared to the same period last year. Adjusted earnings per share reached $2.63, outperforming ****** yst consensus estimates.
The profitability was driven by strong global demand for core oncology and rare disease treatments, which successfully offset revenue headwinds from generic competition affecting older blockbusters like Farxiga and Brilinta. With a net margin hovering around 17.02% and management reiterating its full-year guidance for mid-to-high single-digit revenue growth along with low double-digit core EPS expansion, the core business continues to demonstrate commercial resilience.
The primary driver behind the skepticism could be based on tangible execution risks and regulatory hurdles that threaten AstraZeneca PLC's (NYSE:AZN) long-term top line. A significant blow to the rare disease division came when anselamimab failed to achieve statistical significance for the primary endpoint in the overall AL amyloidosis population in the Phase III CARES program, although AstraZeneca reported encouraging results in a prespecified subgroup of patients with kappa light-chain amyloidosis.
#management
1 month ago
Sep. 12—The Washington State offense couldn't get out of its own way and the Cougar defense was ultimately powerless to slow Kansas State's march as the Wildcats rolled to a 34-7 nonconference football victory Saturday at Bill Snyder Family Stadium in Manhattan, Kan.
After going 0-for-11 on third down during the Apple Cup, the Cougars' opening script was encouraging.
Quarterback Caden Pinnick rocketed the rock to junior wide receiver Branden Ganashamoorthy and sophomore running back Maxwell Woods for a pair of first downs on WSU's opening drive, but it would be for naught as Cougar kicker Jack Stevens missed his third field goal of the season — matching the total number of misses from last year.
K-State completely snuffed out the Cougs after that, forcing a turnover on downs, nine punts and a forced fumble over the remainder of the game.
The lone bright spot for Wazzu on Saturday were the heroics of WSU safety Jaylen Thomas, who registered the first two interceptions of his college career.
#Third #downs #kansas #wildcats
After going 0-for-11 on third down during the Apple Cup, the Cougars' opening script was encouraging.
Quarterback Caden Pinnick rocketed the rock to junior wide receiver Branden Ganashamoorthy and sophomore running back Maxwell Woods for a pair of first downs on WSU's opening drive, but it would be for naught as Cougar kicker Jack Stevens missed his third field goal of the season — matching the total number of misses from last year.
K-State completely snuffed out the Cougs after that, forcing a turnover on downs, nine punts and a forced fumble over the remainder of the game.
The lone bright spot for Wazzu on Saturday were the heroics of WSU safety Jaylen Thomas, who registered the first two interceptions of his college career.
#Third #downs #kansas #wildcats
1 month ago
Boston Scientific (BSX) trades at about $43, roughly 17% below the recent high it set on 19th Aug, 2026. Its own history with sharp drops is encouraging. That history does not cover a cyberattack it says is likely to hit its 2026 results, and the stock is down about 60% over the past twelve months. Start with the history.
Since 2010, Boston Scientific has fallen 20% or more inside 30 trading days six times. Four are old enough to have a full year behind them, and all four ended higher twelve months later, at a median gain of 18%. The two most recent are too young to have a one-year result.
Collecting that gain was uncomfortable. Among those four, the median buyer sat through a further 17% decline first, and the worst further fall in the whole record was 44%. The median peak gain of 30% took about 226 days to arrive, close to seven and a half months. Waiting, not timing, is what that history rewards.
The record behind those medians is below.
BSX had 6 events since 1/1/2010 where the dip threshold of -20% within 30 days was triggered
#months #boston #scientific
Since 2010, Boston Scientific has fallen 20% or more inside 30 trading days six times. Four are old enough to have a full year behind them, and all four ended higher twelve months later, at a median gain of 18%. The two most recent are too young to have a one-year result.
Collecting that gain was uncomfortable. Among those four, the median buyer sat through a further 17% decline first, and the worst further fall in the whole record was 44%. The median peak gain of 30% took about 226 days to arrive, close to seven and a half months. Waiting, not timing, is what that history rewards.
The record behind those medians is below.
BSX had 6 events since 1/1/2010 where the dip threshold of -20% within 30 days was triggered
#months #boston #scientific
1 month ago
The Cooper Companies Inc. (NASDAQ:COO), a leading medical device company, announced its third quarter fiscal 2026 results on September 9. Topline went up 1% to $1.066 billion in comparison with the same quarter last year, which also included 1% organic growth. The company posted quarterly adjusted diluted EPS of $1.15, which represented a 4% jump from Q3 FY25. During the quarter, $339.1 million was spent on repurchasing around 4.9 million of the company's common shares. This leaves management with $1.5 billion of repurchase capacity, which remains available after the Board had raised its buyback authorization from $2 billion to $3 billion.
The quarter featured several encouraging highlights. These include earnings that exceeded projections, notable growth across the fertility segment within CooperSurgical, record free cash flow generation, and a major tax resolution in the company's favor.
GAAP gross margin went up from 65% in Q3 FY25 to 67% during the recent quarter, largely reflecting the comparison against fiscal 2025 inventory write-downs tied to a CooperSurgical product line exit. Adjusted operating margin improved by 30 basis points to 26%, supported by cost discipline and productivity gains, though partly offset by currency headwinds.
Interest expense fell to $21.5 million from $25.4 million a year prior, reflecting lower rates and reduced average debt. Free cash flow surged 66% to $273.0 million, driven by $341.7 million in operating cash flow less $68.7 million in capital spending.
Due to unfavorable currency movements and rising manufacturing costs, the Q3 gross margin settled at 67% on adjusted basis. This was a 60 basis point drop from Q3 FY25. Certain areas of the business grant caution, such as the CooperVision segment. It generated flat organic growth amid notable weakness across the Asia Pacific and Americas regions.
#billion #cash
The quarter featured several encouraging highlights. These include earnings that exceeded projections, notable growth across the fertility segment within CooperSurgical, record free cash flow generation, and a major tax resolution in the company's favor.
GAAP gross margin went up from 65% in Q3 FY25 to 67% during the recent quarter, largely reflecting the comparison against fiscal 2025 inventory write-downs tied to a CooperSurgical product line exit. Adjusted operating margin improved by 30 basis points to 26%, supported by cost discipline and productivity gains, though partly offset by currency headwinds.
Interest expense fell to $21.5 million from $25.4 million a year prior, reflecting lower rates and reduced average debt. Free cash flow surged 66% to $273.0 million, driven by $341.7 million in operating cash flow less $68.7 million in capital spending.
Due to unfavorable currency movements and rising manufacturing costs, the Q3 gross margin settled at 67% on adjusted basis. This was a 60 basis point drop from Q3 FY25. Certain areas of the business grant caution, such as the CooperVision segment. It generated flat organic growth amid notable weakness across the Asia Pacific and Americas regions.
#billion #cash
1 month ago
SailPoint Inc. (NASDAQ:SAIL), a leading player within the enterprise identity security ***** e, released its fiscal second-quarter 2027 on September 9. The company registered a 25% growth in its annual recurring revenue compared to the same period last year, with figures of $1.231 billion. This was driven by a 36% expansion in SaaS ARR which clocked in at $847 million. SailPoint generated $45 million in operating cash flow during the quarter, along with $37 million in free cash flow.
Burben/Shutterstock.com
Topline for the quarter hit $309 million, exhibiting 17% growth compared to Q2 FY26, amid several underlying factors. The company's subscription revenue reached $295 million, up 19% from a year earlier. SaaS customer base increased by 16%, with net new SaaS ARR jumping 34% year-over-year. It contributed around 97% to overall net new ARR for the business, with AI-driven ARR crossing $70 million mark.
SailPoint's existing customer base showed highly encouraging trends in adopting the company's AI-enabled solutions, with a 60% increase in their annual spend during the second quarter. These solutions were incorporated within more than two-thirds of the completed migrations during the quarter. Quarterly adjusted operating income increased from $54 million a year prior to $63 million, translating into an adjusted margin of 20%.
The quarter also saw key strategic moves by the management. It introduced the SailPoint Identity Security solution, which integrates SailPoint Agentic Fabric with SailPoint Human Fabric to deliver a real-time cycle for discovering and securing intricate digital ecosystems. The company also launched its Cursor Enterprise connector, which enables enterprises to manage both autonomous AI agents and human developers through an integrated control plane.
#year #SaaS #fabric #identity
Burben/Shutterstock.com
Topline for the quarter hit $309 million, exhibiting 17% growth compared to Q2 FY26, amid several underlying factors. The company's subscription revenue reached $295 million, up 19% from a year earlier. SaaS customer base increased by 16%, with net new SaaS ARR jumping 34% year-over-year. It contributed around 97% to overall net new ARR for the business, with AI-driven ARR crossing $70 million mark.
SailPoint's existing customer base showed highly encouraging trends in adopting the company's AI-enabled solutions, with a 60% increase in their annual spend during the second quarter. These solutions were incorporated within more than two-thirds of the completed migrations during the quarter. Quarterly adjusted operating income increased from $54 million a year prior to $63 million, translating into an adjusted margin of 20%.
The quarter also saw key strategic moves by the management. It introduced the SailPoint Identity Security solution, which integrates SailPoint Agentic Fabric with SailPoint Human Fabric to deliver a real-time cycle for discovering and securing intricate digital ecosystems. The company also launched its Cursor Enterprise connector, which enables enterprises to manage both autonomous AI agents and human developers through an integrated control plane.
#year #SaaS #fabric #identity
